Skip to content

Clinical trials

Completed Phase 1/2 trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Completed Country / region: Russia Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20063
20071
20084
20095
20106
20112
20122
20135
20144
20156
20166
20174
20185
202010
20214
20223
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed78

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
St. Petersburg State Pavlov Medical University6
Russian Academy of Medical Sciences4
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation3
Novartis Pharmaceuticals3
Pfizer3
Tomsk National Research Medical Center of the Russian Academy of Sciences3
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation2
Genzyme, a Sanofi Company2
Ionis Pharmaceuticals, Inc.2
Kidney Cancer Research Bureau2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1910
Neoplasms5
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Coronavirus Infections3
Hodgkin Disease3
Immune System Diseases3
Small Cell Lung Carcinoma3
Arthritis, Rheumatoid2
Autism Spectrum Disorder2

Trials

Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.